{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T09:45:37Z","timestamp":1775123137227,"version":"3.50.1"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:p>\n                    A 59-year-old man with metastatic melanoma and brain metastases underwent brain radiotherapy. Following treatment, he developed neurological symptoms, prompting further evaluation. To assess the treatment response and possibility of Lutetium-177-FAPI therapy, both\n                    <jats:sup>18<\/jats:sup>\n                    F-FDG PET\/CT and\n                    <jats:sup>68<\/jats:sup>\n                    Ga-FAPI-46 PET\/CT scans were performed. The\n                    <jats:sup>18<\/jats:sup>\n                    F-FDG PET\/CT was inconclusive due to posttreatment changes, making it challenging to distinguish between tumor progression and therapy-related alterations. In contrast, the\n                    <jats:sup>68<\/jats:sup>\n                    Ga-FAPI-46 PET\/CT revealed multiple areas of increased FAPI uptake, indicative of viable residual lesions and consistent with MRI findings.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000005985","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T23:00:21Z","timestamp":1755039621000},"page":"e132-e133","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Comparative Utility of 68Ga-FAPI PET\/CT and 18F-FDG PET\/CT in Assessing Treatment Response in a Case of Metastatic Anal Melanoma With Brain Involvement"],"prefix":"10.1097","volume":"51","author":[{"given":"Ghasemali","family":"Divband","sequence":"first","affiliation":[{"name":"Jam Nuclear Medicine Center, Jam Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoume","family":"Chehrara","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, School of Medicine, Rajaie Cardiovascular, Medical and Research Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nastaran","family":"Khodakarim","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Hematology, Hazrat-e Rasool Hospital, School of Medicine, Iran University of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamidreza","family":"Amini","sequence":"additional","affiliation":[{"name":"Khatam PET\/CT Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8958-8848","authenticated-orcid":false,"given":"Leila","family":"Hassanzadeh","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, School of Medicine, Rajaie Cardiovascular, Medical and Research Center"},{"name":"Department of Molecular Imaging, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"R1-20260107","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.2967\/jnumed.118.224469","article-title":"Development of fibroblast activation protein\u2013targeted radiotracers with improved tumor retention","volume":"60","author":"Loktev","year":"2019","journal-title":"J Nucl Med"},{"key":"R2-20260107","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2967\/jnumed.119.227967","article-title":"68Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer","volume":"60","author":"Kratochwil","year":"2019","journal-title":"J Nucl Med"},{"key":"R3-20260107","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2967\/jnumed.118.215913","article-title":"68Ga-FAPI PET\/CT: biodistribution and preliminary dosimetry estimate of 2 DOTA-containing FAP-targeting agents in patients with various cancers","volume":"60","author":"Giesel","year":"2019","journal-title":"J Nucl Med"},{"key":"R4-20260107","first-page":"1097","article-title":"Recent clinical implications of FAPI: imaging and therapy","volume":"10","author":"Kiani","year":"2022","journal-title":"Clin Nucl Med"},{"key":"R5-20260107","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/RLU.0000000000004479","article-title":"68Ga-FAPI PET\/CT imaging of intracranial syphilitic gumma: comparison to: 18: F-FDG PET\/CT","volume":"48","author":"Gong","year":"2023","journal-title":"Clin Nucl Med"},{"key":"R6-20260107","first-page":"1097","article-title":"Elevated 68Ga-FAPI-04 activity due to Staphylococcus aureus intracranial infection","volume":"10","author":"Zhang","year":"2022","journal-title":"Clin Nucl Med"},{"key":"R7-20260107","first-page":"1097","article-title":"Cerebral echinococcosis mimicking malignancy on 68Ga-FAPI PET\/MR","volume":"10","author":"Zhou","year":"2022","journal-title":"Clin Nucl Med"},{"key":"R8-20260107","doi-asserted-by":"crossref","first-page":"1436009","DOI":"10.3389\/fonc.2024.1436009","article-title":"[68Ga] Ga-FAPI PET\/CT in brain tumors: comparison with [18F] F-FDG PET\/CT","volume":"14","author":"Liu","year":"2024","journal-title":"Front Oncol"},{"key":"R9-20260107","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3390\/ph16040521","article-title":"Head-to-head comparison between [68Ga] Ga-DOTA. SA. FAPi and [18F] F-FDG PET\/CT imaging in patients with breast cancer","volume":"16","author":"Ballal","year":"2023","journal-title":"Pharmaceuticals"},{"key":"R10-20260107","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1007\/s00259-020-04769-z","article-title":"Comparison of [68 Ga] Ga-DOTA-FAPI-04 and [18 F] FDG PET\/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer","volume":"47","author":"Chen","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R11-20260107","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1007\/s00259-022-05702-2","article-title":"[68 Ga] Ga-FAPI versus [18F] F-FDG in malignant melanoma: complementary or counterpoint?","volume":"49","author":"Mokoala","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R12-20260107","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/RLU.0000000000003357","article-title":"Increased FAPI uptake in brain metastasis from lung cancer on 68Ga-FAPI PET\/CT","volume":"46","author":"Fu","year":"2021","journal-title":"Clin Nucl Med"},{"key":"R13-20260107","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1007\/s00259-024-07062-5","article-title":"Assessment of viable tumours by [68Ga] Ga-FAPI-04 PET\/CT after local regional treatment in patients with hepatocellular carcinoma","volume":"52","author":"Zhu","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R14-20260107","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.37349\/etat.2024.00276","article-title":"Preliminary evaluation of FAPI-04-PET\/CT for differentiating recurrence and post-treatment changes in high-grade gliomas","volume":"5","author":"Dev","year":"2024","journal-title":"Explor Target Antitumor Ther"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005985","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T19:00:49Z","timestamp":1767812449000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005985","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"assertion":[{"value":"2025-02-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}